Earlier this year, I profiled one of the best stocks in the perennially un-sexy aftermarket auto parts sector. This stock is still an incredible buy for patient, conservative investors focused on the long haul.
After delivering 9% (including dividends) since my recommendation, shares of Genuine Parts Co. (NYSE: GPC) now trade at an attractive 15% discount to their 52-week high. Despite the rise and sudden drop, my original investment thesis is still intact.
As I pointed out in the previous article, the U.S. aftermarket auto parts space is still highly fragmented. While the big national players such as GPC, O’Reilly (Nasdaq: ORLY), and AutoZone (NYSE: AZO) seem to have a gigantic presence, mom and pop operations are still relevant players on a market share basis. However, consolidating within that independent space is GPC’s growth strategy.
Recently, the company closed on two acquisitions: Apache Hose and Belting Company and Monroe Motor Products. With these two smart buys, GPC was able to add another $125 million to its current annual revenue number of $15.28 billion. They also help solidify GPC’s automotive and industrial supply footprint.
financial stocks to buy: GlaxoSmithKline PLC(GSK)
- [By Keith Speights]
Gilead’s primary rival in the HIV market is Viiv Healthcare, which is majority-owned byGlaxoSmithKline (NYSE:GSK).The company recently announced positive results from a late-stage clinical study of its HIV drug Tivicay combined with Johnson & Johnson’s Edurant.
- [By WWW.THESTREET.COM]
Up first on our list of potentially toxic trades is $98 billion healthcare stock GlaxoSmithKline plc (GSK) . GSK has actually been an attractive name to own lately. Shares are up about 10.6% since bottoming back in December, besting the S&P over that timeframe. But if you own GlaxoSmithKline, now’s the time to start thinking about taking some of those recent gains off the table — shares are looking “toppy” this spring.
- [By Paul Ausick]
GlaxoSmithKline plc (NYSE: GSK) dropped about 1% Wednesday to post a new 52-week low of $34.52 after closing at $34.86 on Tuesday. The stock’s 52-week high is $44.54. Volume of around 4.8 million was about equal to the daily average. The company’s HIV drug is being challenged by a potentially better drug from competitor Gilead Sciences.
- [By Todd Campbell]
Also, like in hepatitis C, competitors are attempting to win away market share. For example,ViiV Healthcare, a joint venture spearheaded by GlaxoSmithKline(NYSE:GSK), is actively pursuing new HIV therapies that could make it more difficult for Gilead Sciences to maintain its market share dominance. In December, ViiV announced that a single tablet, two-drug combination that includes Johnson & Johnson’s Edurant met its primary endpoint in phase 3 studies. A filing for FDA approval is slated for this year.
financial stocks to buy: Netease.com Inc.(NTES)
- [By Joe Tenebruso]
Shares ofNetEase (NASDAQ:NTES)popped 20.1% last month, according to data provided byS&P Global Market Intelligence, as the Chinese internet technology company’s strong fourth-quarter earnings report was applauded by investors.
- [By Sreekanth Anasa]
Shares of Hangzhou, China-based NetEase Inc (NASDAQ:NTES)popped 14% in the Feb 16th trading session after the company reported stellar Q4 and full-year 2016 earnings on Feb 15th after market close. The Chinese online gaming giant delivered an EPS of $4.30 on revenues of $1.74B beating EPS estimates by $0.86 and revenue estimates by $16oM. NetEase’s revenue grew by an impressive 53.1% YoY for Q4 and 67.7% for the full year 2016. On the back of these strong numbers, NTES stock closed at an all-time high of $298.73 in yesterday’s trading session. NTES stock might have gone up very high too soon. There could be a correction around the corner but still NTES stock is a great long-term proposition with much more upside left. Here’s why.
financial stocks to buy: Black Box Corporation(BBOX)
- [By Monica Gerson]
Black Box Corporation (NASDAQ: BBOX) is expected to post its quarterly earnings at $0.26 per share on revenue of $218.41 million.
Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets
financial stocks to buy: Mitel Networks Corporation(MITL)
- [By Lisa Levin]
ShoreTel Inc (NASDAQ: SHOR) shares shot up 28 percent to $7.47. Mitel Networks Corp (NASDAQ: MITL) announced plans to acquire Shortel for $7.50 per share in cash.
financial stocks to buy: Fitbit, Inc.(FIT)
- [By Paul Ausick]
Fitbit Inc. (NYSE: FIT) dropped about 3.2% Thursday, to post a new 52-week low of $7.01 after closing at $7.24 on Wednesday. The stock’s 52-week high is $19.34. Volume was about 10% below the daily average of around 11.7 million shares. The company had no specific news.
- [By Paul Ausick]
Fitbit Inc. (NYSE: FIT) lost about 2.4% Tuesday to post a new 52-week low of $8.20 after closing Monday at $8.40. The 52-week high is $34.68. Volume of around 7.1 million was about 30% below the daily average of around 1 million shares traded. The company had no specific news Tuesday.
- [By Nicholas Rossolillo]
It has been a year worth forgetting for shareholders of Fitbit (NYSE:FIT). The wearables maker has seen sales sputter and profitability took a big hit thanks to a steep increase in expenses. However, much of that money has been aggressively put into research and development in the past year. While that has contributed to the dismal-looking bottom line, investing for the future is a good thing.
- [By James E. Brumley]
While the economy’s natural — and recurring — cycles favor different kinds of stocks at different times, not every great trend is necessarily a cyclical one. Sometimes, a trend is rooted in a technological development that changes cultural norms. The advent of the smartphone, for example, has made constant connectivity to the world around part of how we live our daily lives.
These mega-trends present tremendous opportunities for investors too, provided they’re savvy enough to see them coming and play them the right way.
One such mega-trend newly underway right now is the proliferation of wearables… devices that meld clothing (often a wrist-worn device) and technology to perform a function that couldn’t be performed otherwise. Much of the same technology that made the smartphone possible are now ushering in wearables.
It’s not been a smooth beginning. however.
While the buzz was strong and expectations reached a peak two years ago when Fitbit Inc (NYSE:FIT) was all the rage and in the wake of its IPO, the company’s growth wasn’t to be sustained. The company is struggling to muster any growth now, and FIT shares have fallen to a tenth of their value seen in late-2015, when the euphoria was strongest.
Fitbit’s slowdown has been mirrored by other companies in the space. The wearables market only grew 3.1% in Q3 of 2016.
On the flipside, while the debacle of Fitbit — the wearable industry’s iconic company — has been a painful, it’s also been a learning experience. And, it’s not as if the slowdown is unfurling without the wearables market never reaching a respectable size. International Data Corporation estimates were 23 million ‘wearables’ delivered in the third quarter of last year alone.
Moreover, the fizzling of the market hasn’t turned into a reason to swear off wearables as an investment opportunity… quite the opposite, actually. It’s just now become considerably clearer what consumers want an
- [By Ashley Moore]
We saw it with GoPro Inc. (Nasdaq: GPRO) and Fitbit Inc. (NYSE: FIT). Both are trading about 90% below their post-IPO peak prices.
“The thought that any sane investor would buy Snapchat is frightening,” said Money Morning Capital Wave Strategist Shah Gilani. “Buying shares in SNAP is like trying to pick up nickels in front of buses.”
financial stocks to buy: Pilbara Minerals Limited (PILBF)
- [By SEEKINGALPHA.COM]
The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].
- [By SEEKINGALPHA.COM]
The question now is more about speed of EV implementation. On the supply side, it has been great to see LAC, Pilbara Minerals (OTCPK:PILBF) and Altura Mining (OTCPK:ALTAF) get funding, but the continued issues with Albemarle’s (NYSE:ALB) LaNegra II expansion and Orocobre (OTCPK:OROCF) ramping up to Phase 1 capacity of 17,500 tonnes/year of lithium carbonate are further evidence that lithium projects take time and have considerable execution risk.